Investor FAQs

What are the head office contact details for Amplia Therapeutics?

Level 17
350 Queen Street
Melbournce, VIC, 3000

What is the name and contact details of Amplia Therapeutics Share Registry?

Computershare Investor Services Pty Limited
Telephone: 1300 850 505 (within Australia)
         + 61 3 9415 4000 (outside Australia)

Who are the auditors for Amplia Therapeutics?

Grant Thornton Audit Pty
Collins Square, Tower 1
727 Collins Street
Melbourne Victoria 3008

What is the financial year end for Amplia Therapeutics?

Amplia Therapeutics' financial year ends 31 March each year.

How can I obtain a copy of the annual report for Amplia Therapeutics?

A copy of the Annual Report can be downloaded from the Investor Information tab on this site. The report is available for download in Adobe Acrobat format. You will have to have Adobe Acrobat Reader installed on your computer to view it.

To install Adobe Acrobat Reader please go to:

Alternately, should you require a printed copy, please contact us for one to be sent to you via post.

How can I obtain announcements made to the market by Amplia Therapeutics?

These announcements are available in the ASX Announcements section of our website or by accessing the archive section of the Australian Stock Exchange – ASX:ATX.

How do I unsubscribe from email alerts on progress made by Amplia Therapeutics?

To unsubscribe at any time please visit the email alerts page and click the unsubscribe link on that page.

What is Amplia Therapeutics privacy policy?

You can find our Privacy Policy here.

Who is Amplia Therapeutics' Company Secretary and how can I contact him?

Andrew J. Cooke
Mobile: + 61 (0) 412 090 826

How do I update my address and contact preferences?

You can update your contact details and preferences by creating an account at the Computershare Investor Centre. You will need your Shareholder Registration Number (SRN) which you can obtain from your Holding Statement.